Is Hikal technically bullish or bearish?

Overview of Current Technical Trends

As of 3 December 2025, Hikal’s technical trend has transitioned from a clear bearish stance to a mildly bearish one. This subtle shift indicates that while downward pressure remains, the intensity of the decline has somewhat eased. The stock’s current price stands at ₹243.75, having opened the day with a low of ₹227.40 and reaching a high of ₹254.60, reflecting intraday volatility within a relatively narrow range.

Examining the 52-week range, Hikal’s shares have traded between ₹217.35 and ₹464.50, highlighting significant depreciation from its peak over the past year. This wide range underscores the challenges the stock has faced amid broader market conditions and sector-specific headwinds.

Mixed Signals from Key Technical Indicators

The Moving Average Convergence Divergence (MACD) indicator offers a split view: weekly readings are mildly bullish, suggesting some short-term upward momentum, whereas monthly readings remain bearish, signalling longer-term weakness. This divergence implies that while short-term traders might find opportunities, the broader trend remains under pressure.

The Relative Strength Index (RSI), a momentum oscillator, currently provides no clear signal on either weekly or monthly timeframes. This neutrality suggests the stock is neither overbought nor oversold, leaving room for directional movement in either direction depending on market catalysts.

Bollinger Bands, which measure volatility and potential price extremes, indicate a mildly bearish stance on both weekly and monthly charts. This suggests that the stock price is closer to the lower band, often interpreted as a sign of weakness or potential overselling, but not yet at an extreme level warranting a strong reversal.

Moving Averages and Other Momentum Indicators

Daily moving averages for Hikal are mildly bearish, reinforcing the notion that the stock is under modest downward pressure in the short term. The Know Sure Thing (KST) indicator, which aggregates multiple momentum signals, aligns with the MACD by showing mild bullishness on the weekly scale but bearishness monthly. This again highlights the contrast between short-term optimism and longer-term caution.

Dow Theory analysis echoes this pattern, with weekly signals mildly bullish but monthly trends bearish. This theory, which focuses on the confirmation of trends across different market segments, suggests that while some short-term strength exists, the overall market sentiment for Hikal remains subdued.

On-Balance Volume (OBV), a volume-based indicator that can signal accumulation or distribution, is mildly bearish on the weekly chart and shows no clear trend monthly. This lack of strong volume support may limit the sustainability of any short-term rallies.

Performance Comparison with Sensex

Hikal’s recent returns paint a challenging picture relative to the broader market benchmark, the Sensex. Over the past week, the stock has outperformed with a gain of 10.17%, while the Sensex declined by 0.59%. This short-term strength could be attributed to bargain hunting or sector-specific developments.

However, over longer periods, Hikal has underperformed significantly. The one-month return is slightly negative at -0.33%, compared to the Sensex’s positive 1.34%. Year-to-date, the stock has declined by 37.46%, starkly contrasting with the Sensex’s 8.92% gain. Over one year, the disparity widens further, with Hikal down 45.10% against the Sensex’s 5.27% rise.

Even over three and five years, Hikal’s returns lag the Sensex considerably, with the stock down 28.83% over three years versus the Sensex’s 35.37% gain, and a 40.09% gain over five years compared to the Sensex’s 90.68%. The ten-year horizon shows some recovery with a 140.54% gain, but still trails the Sensex’s 228.77% growth.

Interpreting the Technical Outlook

The technical data for Hikal suggests a stock caught between cautious optimism and persistent bearish undertones. Weekly indicators such as MACD, KST, and Dow Theory hint at mild bullish momentum, which could attract short-term traders looking for entry points. However, the monthly indicators and moving averages caution investors about the prevailing downtrend and the absence of strong volume support.

Given the stock’s significant underperformance relative to the Sensex over multiple timeframes, investors should weigh the technical signals against fundamental factors and sector dynamics. The pharmaceutical and biotechnology industry often experiences volatility due to regulatory developments, research outcomes, and market sentiment shifts, which can impact technical patterns.

Moreover, the stock’s proximity to its 52-week low and the mild bearishness in Bollinger Bands suggest that while the downside may be limited, a sustained recovery is not yet confirmed. The lack of clear RSI signals further emphasises the uncertainty in momentum direction.

Conclusion: A Mildly Bearish Stance with Short-Term Bullish Pockets

In summary, Hikal’s technical profile as of December 2025 is best characterised as mildly bearish overall, with intermittent signs of short-term bullishness. The shift from outright bearish to mildly bearish indicates some easing of selling pressure, but the absence of strong monthly momentum and volume support tempers enthusiasm.

Investors considering Hikal should approach with caution, recognising that while short-term rallies may occur, the longer-term trend remains challenged. Monitoring key technical indicators for confirmation of trend reversals, alongside fundamental developments in the pharmaceutical sector, will be crucial for informed decision-making.

For those seeking exposure to the pharmaceuticals and biotechnology space, it may be prudent to explore alternative stocks with stronger technical and fundamental profiles, especially given Hikal’s relative underperformance and mixed signals.

Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →